je.st
news
Tag: compared
Grafix Demonstrates Superior Clinical Outcomes Compared With EpiFix In Real World' Study
2016-05-03 03:28:13| drugdiscoveryonline News Articles
Osiris Therapeutics, Inc., a leading cellular and regenerative medicine company, focused on developing and marketing products to treat conditions in wound care, orthopaedics and sports medicine, announces the results of A Retrospective, Single-Center, Non-Randomized, Cross-Sectional Comparative Effectiveness Study Evaluating Surface Area Reduction, Volume Reduction and Closure Rates in Acute and Chronic Wounds Managed with Grafix versus EpiFix
Tags: real
world
study
compared
New Study Shows IFCO Reusable Plastic Containers Generate 31% Less CO2 Compared To Cardboard Boxes
2016-04-25 04:23:53| pollutiononline Home Page
IFCO recentlyreleased the results of a new peer-reviewed life cycle analysis (LCA) study comparing Reusable Plastic Containers (RPCs) and corrugated cardboard containers used to package and transport fresh produce from farms to retail locations
Mercks ZEPATIER (Elbasvir and Grazoprevir) Showed Superiority on Efficacy and Safety Endpoints Compared to Sofosbuvir Plus Peginterferon and Ribavirin Treatment Regimen in Phase 3 Trial
2016-04-14 07:00:00| Merck.com - Corporate News
Dateline City: KENILWORTH, N.J. Results From C-EDGE Head-to-Head Study in Patients with Chronic Hepatitis C Genotypes 1 or 4 Infection Presented at The International Liver Congress 2016 KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the presentation of results from C-EDGE Head-to-Head, the companys comparative, Phase 3, open-label clinical trial evaluating the efficacy and safety of ZEPATIER (elbasvir and grazoprevir) 50mg/100mg tablets versus a regimen of sofosbuvir 400mg tablets plus peginterferon and ribavirin (pegIFN/RBV) in treatment-nave and pegIFN/RBV treatment-experienced patients with chronic hepatitis C (HCV) genotype (GT) 1 or GT4 infect Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558Sarra Herzog, 201-669-6570orInvestors:Teri Loxam, 908-740-1986Amy Klug, 908-740-1898 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: in
safety
treatment
trial
CEO pay at Tampa Bay public corporations? Big to us but tiny compared to top U.S. execs
2016-04-09 17:34:26| Mobile Homes - Topix.net
Among the CEOs of Tampa Bay's larger publicly traded corporations, Mark Mondello of Jabil enjoyed the biggest paycheck of the past year, in addition to the greatest annual raise in compensation. In contrast, founder and CEO Paresh Patel of the property insurer HCI Group saw his compensation drop sharply from the year before, according to currently available data.
Annaly Capital's BV, Dividend, And Valuation Compared To 19 mREIT...
2016-04-04 16:25:07| Real Estate - Topix.net
This article compares NLY's recent dividend per share rates, yield percentages and several dividend sustainability metrics to nineteen mREIT peers. This article also explains why NLY had a stable dividend for the first quarter of 2016 .
Tags: to
compared
valuation
dividend
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] next »